PEELHOUSE MEDICAL PLAZA
PEEL HOUSE MEDICAL PLAZA, PEEL HOUSE LANE, WIDNESHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 47 | 59 | 79.7% | |
HF 4 | 2011 | 54 | 64 | 84.4% | |
HF 4 | 2012 | 78 | 88 | 88.6% | |
HF 4 | 2013 | 96 | 103 | 93.2% | |
HF004 | 2014 | 47 | 49 | 95.9% | |
HF004 | 2015 | 46 | 50 | 92.0% | |
HF004 | 2016 | 51 | 51 | 100.0% | |
HF004 | 2017 | 51 | 57 | 89.5% | |
HF004 | 2018 | 52 | 59 | 88.1% | |
HF004 | 2019 | 55 | 66 | 83.3% | |
HF004 | 2020 | 43 | 47 | 91.5% | |
HF006 | 2021 | 57 | 64 | 89.1% | |
HF006 | 2022 | 72 | 76 | 94.7% | |
HF006 | 2023 | 89 | 92 | 96.7% |